Beta-blocking drugs in migraine.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000517:prevention & control*; D011247:Pregnancy; D011433:Propranolol / Q000627:therapeutic use; D011943:Receptors, Adrenergic, beta / Q000187:drug effects; D012702:Serotonin Antagonists; D013999:Timolol / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D011943:Receptors, Adrenergic, beta; D012702:Serotonin Antagonists; D013999:Timolol; D011433:Propranolol